Page last updated: 2024-09-04

moxifloxacin and eye

moxifloxacin has been researched along with eye in 12 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (eye)	Trials (eye)	Recent Studies (post-2010) (eye)
3,157	552	1,690	41,716	724	8,737

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (50.00)	29.6817
2010's	5 (41.67)	24.3611
2020's	1 (8.33)	2.80

Authors

Authors	Studies
Bitterman, A; Chruscicki, DA; Cohn, S; Donnenfeld, E; Perry, HD; Solomon, R	1
Blondeau, JM; Hedlin, P	1
Giamarellos-Bourboulis, EJ; Kanellakopoulou, K; Kranidioti, H; Liarakos, V; Papathanassiou, M; Theodossiadis, P; Tsaganos, T; Tzepi, I; Vergados, I	1
Choi, JS; Joo, CK; Kim, KA; Lim, JA; Park, SH	1
A, AK; Alge, CS; Eibl, KH; Kernt, M; Lackerbauer, CA; Liegl, RG; Neubauer, AS; Ulbig, MW	1
Kobayakawa, S; Ooki, K; Tochikubo, T; Tsuji, A	1
Carter, NJ; Scott, LJ	1
Davis, LT; Fiscella, RG; Glickman, RD; Kumar, N; Nijm, LM; Peterson, RJ; Tu, EY; Ulanski, LJ	1
Proksch, JW; Ward, KW	1
Keating, GM	1
Celen, MK; Ozekinci, S; Sakalar, YB	1
Hinkle, DM	1

Reviews

1 review(s) available for moxifloxacin and eye

Article	Year
Moxifloxacin 0.5% ophthalmic solution: in bacterial conjunctivitis. Drugs, 2011, Jan-01, Volume: 71, Issue:1 Topics: Anti-Bacterial Agents; Aza Compounds; Clinical Trials as Topic; Conjunctivitis, Bacterial; Eye; Fluoroquinolones; Humans; Moxifloxacin; Multicenter Studies as Topic; Ophthalmic Solutions; Quinolines; Randomized Controlled Trials as Topic	2011

Trials

1 trial(s) available for moxifloxacin and eye

Article	Year
A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability. Current medical research and opinion, 2004, Volume: 20, Issue:11 Topics: Adult; Anterior Chamber; Aza Compounds; Conjunctiva; Eye; Female; Fluoroquinolones; Gatifloxacin; Humans; Hyperemia; Irritants; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Pain; Pupil; Quinolines	2004

Article

Year

A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability.

Current medical research and opinion, 2004, Volume: 20, Issue:11

Topics: Adult; Anterior Chamber; Aza Compounds; Conjunctiva; Eye; Female; Fluoroquinolones; Gatifloxacin; Humans; Hyperemia; Irritants; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Pain; Pupil; Quinolines

2004

Other Studies

10 other study(ies) available for moxifloxacin and eye

Article	Year
Comparative minimal inhibitory and mutant prevention drug concentrations of four fluoroquinolones against ocular isolates of Haemophilus influenzae. Eye & contact lens, 2007, Volume: 33, Issue:3 Topics: Anti-Infective Agents; Antimutagenic Agents; Aza Compounds; Ciprofloxacin; Dose-Response Relationship, Drug; Eye; Fluoroquinolones; Gatifloxacin; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Osmolar Concentration; Quinolines	2007
Pharmacokinetics of intravenously administered moxifloxacin in eye compartments: an experimental study. International journal of antimicrobial agents, 2009, Volume: 33, Issue:2 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Chromatography, High Pressure Liquid; Eye; Fluoroquinolones; Infusions, Intravenous; Male; Models, Animal; Moxifloxacin; Plasma; Quinolines; Rabbits	2009
The resistance patterns of normal ocular bacterial flora to 4 fluoroquinolone antibiotics. Cornea, 2009, Volume: 28, Issue:1 Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Bacteria, Aerobic; Ciprofloxacin; Conjunctiva; Eye; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines	2009
Intracameral moxifloxacin: in vitro safety on human ocular cells. Cornea, 2009, Volume: 28, Issue:5 Topics: Anti-Infective Agents; Aza Compounds; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Administration Schedule; Endothelium, Corneal; Eye; Fluoroquinolones; Humans; In Vitro Techniques; Moxifloxacin; Quinolines; Retinal Pigment Epithelium; Trabecular Meshwork	2009
Aqueous humor penetration of fourth-generation fluoroquinolone ophthalmic solutions given by multiple administration in a rabbit model. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2009, Volume: 15, Issue:4 Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Cataract Extraction; Drug Administration Schedule; Eye; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Models, Animal; Moxifloxacin; Ophthalmic Solutions; Quinolines; Rabbits; Surgical Wound Infection	2009
Besifloxacin ophthalmic suspension 0.6%. Drugs, 2010, Volume: 70, Issue:1 Topics: Administration, Topical; Anti-Bacterial Agents; Antifungal Agents; Aza Compounds; Azepines; Colony Count, Microbial; Conjunctivitis, Bacterial; DNA Gyrase; DNA Topoisomerase IV; Double-Blind Method; Drug Administration Schedule; Eye; Fluoroquinolones; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Ophthalmic Solutions; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Suspensions	2010
An adaptable HPLC method for the analysis of frequently used antibiotics in ocular samples. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2010, Sep-15, Volume: 878, Issue:26 Topics: Acetamides; Animals; Anti-Bacterial Agents; Aza Compounds; Cefuroxime; Chromatography, High Pressure Liquid; Contact Lenses, Hydrophilic; Eye; Fluoroquinolones; Gatifloxacin; Linear Models; Linezolid; Moxifloxacin; Oxazolidinones; Quinolines; Rabbits; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Vitreous Body	2010
Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2010, Volume: 26, Issue:5 Topics: Administration, Topical; Animals; Aqueous Humor; Area Under Curve; Aza Compounds; Azepines; Conjunctivitis, Bacterial; Eye; Fluoroquinolones; Gatifloxacin; Haemophilus Infections; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Streptococcal Infections	2010
Treatment of experimental Bacillus cereus endophthalmitis using intravitreal moxifloxacin with or without dexamethasone. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2011, Volume: 27, Issue:6 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Bacillus cereus; Colony Count, Microbial; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Eye; Fluoroquinolones; Intravitreal Injections; Moxifloxacin; Quinolines; Rabbits; Time Factors; Treatment Outcome	2011
Re-assessing Evidence for Adverse Ocular Reactions Associated with Fluoroquinolones: Implications for Intracameral Use. Ocular immunology and inflammation, 2022, 01-02, Volume: 30, Issue:1 Topics: Anti-Bacterial Agents; Endophthalmitis; Eye; Fluoroquinolones; Humans; Moxifloxacin	2022